Published in Circ Res on February 22, 2002
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev (2011) 5.51
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci U S A (2004) 4.31
ECM remodeling in hypertensive heart disease. J Clin Invest (2007) 4.03
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell (2008) 3.56
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol (2007) 3.19
Progress in matrix metalloproteinase research. Mol Aspects Med (2008) 2.51
Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol (2012) 1.94
Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology (2009) 1.89
Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol (2012) 1.84
Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev (2010) 1.76
Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res (2006) 1.74
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J (2010) 1.63
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol (2009) 1.60
Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost (2007) 1.60
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg (2006) 1.57
Emerging markers of atherosclerosis before and after bariatric surgery. Obes Surg (2015) 1.55
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol (2008) 1.53
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
Dietary cholesterol-induced post-testicular infertility. PLoS One (2011) 1.47
Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery. PLoS One (2015) 1.45
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study. Atherosclerosis (2009) 1.45
Novel NAD(P)H oxidases in the cardiovascular system. Heart (2004) 1.44
Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis (2004) 1.38
Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol (2009) 1.38
Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation (2008) 1.37
Protease-activated drug development. Theranostics (2012) 1.36
MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol (2003) 1.36
MMP induction and inhibition in myocardial infarction. Heart Fail Rev (2004) 1.35
Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 1.33
Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int (2010) 1.29
Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm (2013) 1.25
The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol (2013) 1.25
Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg (2008) 1.23
Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J (2012) 1.21
Molecular imaging in cancer treatment. Eur J Nucl Med Mol Imaging (2010) 1.21
Ceramide: a common pathway for atherosclerosis? Atherosclerosis (2007) 1.19
Coronary artery remodelling is related to plaque composition. Heart (2005) 1.18
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet (2006) 1.18
Molecular events in the cardiomyopathy of sepsis. Mol Med (2008) 1.18
Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1. Am J Physiol Heart Circ Physiol (2009) 1.18
Rapid recruitment of temporally distinct vascular gene sets by estrogen. Mol Endocrinol (2008) 1.16
Arterial stiffness: a brief review. Acta Pharmacol Sin (2010) 1.15
Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res (2010) 1.14
Mechanisms of post-intervention arterial remodelling. Cardiovasc Res (2012) 1.13
IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-kappaB and AP-1 activation. Cell Mol Neurobiol (2009) 1.12
PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol (2008) 1.12
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res (2008) 1.10
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2011) 1.10
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab (2009) 1.10
MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol Cell Proteomics (2008) 1.08
Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol (2005) 1.07
Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol (2005) 1.07
Co-culture induces alignment in engineered cardiac constructs via MMP-2 expression. Biochem Biophys Res Commun (2008) 1.07
Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A (2009) 1.06
Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas. Am J Pathol (2005) 1.06
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels (2007) 1.05
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg (2007) 1.04
Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis (2009) 1.04
Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries. Arterioscler Thromb Vasc Biol (2010) 1.04
Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure. Am Heart J (2008) 1.03
Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta. Circulation (2009) 1.03
Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation. J Nucl Med (2011) 1.03
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol (2008) 1.02
Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol (2006) 1.02
Understanding vascular development. Wiley Interdiscip Rev Dev Biol (2012) 1.02
Enhanced tyrosine nitration of prostacyclin synthase is associated with increased inflammation in atherosclerotic carotid arteries from type 2 diabetic patients. Am J Pathol (2010) 1.01
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm. J Vasc Surg (2006) 1.01
Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation. Int J Legal Med (2010) 1.00
Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology (2007) 1.00
CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study. Pharmacogenet Genomics (2007) 1.00
Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure. Hypertension (2012) 0.99
Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo. J Nucl Med (2010) 0.99
Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.98
Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol (2004) 0.98
Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review. Clin Chem Lab Med (2012) 0.98
Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community. Circulation (2009) 0.97
A multi-layered computational model of coupled elastin degradation, vasoactive dysfunction, and collagenous stiffening in aortic aging. Ann Biomed Eng (2011) 0.97
Mechanical buckling of artery under pulsatile pressure. J Biomech (2012) 0.97
Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness. J Am Soc Echocardiogr (2008) 0.97
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J (2011) 0.97
The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nat Clin Pract Cardiovasc Med (2009) 0.97
Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol (2012) 0.97
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am J Physiol Heart Circ Physiol (2012) 0.96
Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg (2007) 0.96
Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart (2004) 0.96
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res (2007) 0.95
Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch. J Card Surg (2011) 0.95
Portulaca oleracea Ameliorates Diabetic Vascular Inflammation and Endothelial Dysfunction in db/db Mice. Evid Based Complement Alternat Med (2012) 0.95
Vascular damage in giant cell arteritis. Autoimmunity (2009) 0.95
Simulated remodeling of loaded collagen networks via strain-dependent enzymatic degradation and constant-rate fiber growth. Mech Mater (2012) 0.94
Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am J Pathol (2006) 0.94
Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages. Inflammation (2009) 0.94
Regulatory role of mitochondria in oxidative stress and atherosclerosis. World J Cardiol (2010) 0.94
Postthrombotic vein wall remodeling: preliminary observations. J Vasc Surg (2010) 0.94
Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction. Br J Pharmacol (2006) 0.94
Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediators Inflamm (2012) 0.93
Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol (2013) 0.93
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol (2010) 0.93
A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases. Am J Physiol Cell Physiol (2011) 0.93